Bioequivalence of An Oral Mercaptopurine Suspension 100 Mg / 5 Ml Versus Tablet in Healthy Male Subjects Under Fasting Conditions

NCT01697020 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

70

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Lymphoblastic Leukemia

Interventions

DRUG: Mercaptopurine 20mg/ml oral suspension
DRUG: Mercaptopurine 50mg tablet

Sponsor

Nova Laboratories Limited